Michael Frohbergh - Concepedia

Author

Michael Frohbergh

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

, M. Frohbergh, M.E. Frohbergh, Michael E. Frohbergh, Michael Frohbergh

Publications

726

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Temple University Exponent (United States)Massachusetts General Hospital Drexel University

About

Michael Frohbergh is an author at Icahn School of Medicine at Mount Sinai specializing in tissue engineering, regenerative medicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	3	3	458
2	Biomedical Engineering	3	3	458
3	Medicine	2	2	58
4	Cell Biology	2	2	58
5	Orthopaedics	1	1	14

Michael Frohbergh

Publications

666

Citations

H-Index

Page 1

	Year	Citations
Electrospun hydroxyapatite-containing chitosan nanofibers crosslinked with genipin for bone tissue engineering Michael Frohbergh, Anna Katsman, Gregory P. Botta, Biomaterials Tissue EngineeringRegenerative MedicineNanofiberSynthetic Bone SubstituteEngineering	2012	400
Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? Kevin Ong, Douglas P. Beall, Michael Frohbergh, Osteoporosis International	2017	82
Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment Michael Frohbergh, Yi Ge, Fanli Meng, PLoS ONE	2014	45
Osseointegrative Properties of Electrospun Hydroxyapatite-Containing Nanofibrous Chitosan Scaffolds Michael Frohbergh, Anya Katsman, Mark J. Mondrinos, Tissue Engineering Part A Tissue EngineeringOsseointegrative PropertiesEngineeringBone RepairBiofabrication	2014	44
Number Needed to Treat with Vertebral Augmentation to Save a Life Joshua A Hirsch, Ronil V. Chandra, Nicole Carter, American Journal of Neuroradiology	2019	42
Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs Calogera M. Simonaro, Shunji Tomatsu, Tracey Sikora, PLoS ONE	2016	39
Acid ceramidase treatment enhances the outcome of autologous chondrocyte implantation in a rat osteochondral defect model Michael Frohbergh, Johana Guevara, Ronald P. Grelsamer, Osteoarthritis and Cartilage Regenerative MedicineTissue EngineeringEngineeringBone Morphogenic ProteinAcid Ceramidase Treatment	2015	14

Page 1